Our Story · Guelph, Ontario · Founded 2008
A deep science
platform.
Zentek holds a graphite deposit that has demonstrated ultra-high purity in bench scale purification testwork, a growing patent portfolio, and three structurally distinct commercial platforms. New leadership is executing a unified strategy across all three.
deep science platform
\ dēp ˈsī-əns ˈplat-ˌfȯrm \
Industry has a problem; Zentek delivers development-on-demand solutions and secures the IP. One governing model — client-funded research and development, with Zentek retaining commercial ownership of innovations that result.
What we are
One deep science foundation.
Three distinct platforms.
Zentek operates three distinct businesses — Albany Graphite, our graphene platform, and Triera Biosciences. Government grants have the potential to offset a meaningful portion of R&D costs. A patent portfolio that compounds with every engagement.
Zentek is working to advance the three platforms simultaneously — at the convergence of critical minerals supply chain urgency, advanced material performance demand, and next-generation therapeutic development. And in areas of great need, government grants have the potential to offset a meaningful portion of R&D costs. A patent portfolio that has the potential to grow with every engagement.
Client-funded R&D
Industry funds the research program. Zentek develops the solution. Potential development fees generate potential near-term revenue with the goal of generating future royalty streams.
IP ownership
Zentek will seek to retain commercial rights to innovations developed through client engagements, including government funded projects.
Asset-light, high margin
Our focus will be to ensure partners handle production scale-up. Potential premium margins on specialized expertise — the same structure that defines the most valuable specialty chemicals and biotech companies.
Non-dilutive by design
Federal and provincial funding programs have the potential to offset a meaningful portion of R&D costs through non-dilutive funding opportunities.
Three markets, one thesis
Critical minerals supply chain urgency, advanced material performance demand, and next-generation therapeutic development — addressed through one repeatable commercial engine.
Validated deep science
A deposit with 5N purity demonstrated at bench scale, 25+ patent families, and a research base built with McMaster University.
The repositioning
An extraordinary set of opportunities.
A new unified strategy to connect them.
Since December 2025, Zentek has repositioned from a collection of individual projects into a more unified platform company — five strategic shifts, one governing model.
01 · Lead asset defined
The foundational asset.
The Albany graphite deposit is established as our foundational critical mineral asset — 5N purity, low boron, no halogen contamination based on bench-scale testing. Potential to serve mission-critical markets where non-aligned supply is legally or strategically excluded.
Explore Albany
02 · Processing strategy
A materials provider, not a mine.
A potential advanced fluidized bed reactor (“FBR”) processing centre positioned as a materials provider, not a mine — a potential value-added supplier to nuclear, defense, and aerospace applications.
Read The Graphite Divide
03 · Coatings reframed
Development-on-demand graphene.
From a product company to a development-on-demand graphene-based solutions provider: industry has a problem, we deliver solutions and seek to secure the IP.
See the graphene platform
04 · Life sciences crystallised
An aptamer contract research organization.
Triera Biosciences is positioning itself for potential custom discovery, rapid diagnostics, and therapeutic development. The same client-funded, IP-ownership model applied to biotech.
Explore Triera
05 · One story
One deep science platform.
Zentek as a deep science platform company: validated assets, 25+ patent families, three distinct markets, one governing model.
Investor overviewIndustry has a problem, we deliver development-on-demand solutions and secure the IP.
Leadership team
The team executing the plan.
New leadership since December 2025 is executing a unified strategy across all three platforms.
Company credentials
A Well-established Base.
Guelph, Ontario
Graphene synthesis · coating application · laboratory testing · 25,000 sq ft.
~70 km NW of Hearst, Ontario
Porcupine Mining District · Our foundational critical mineral asset.
McMaster University
Exclusive 20-year aptamer license · 588 combined team publications · electrochemical sensor development · machine learning classification.